VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
Stock Information for VBI Vaccines Inc.
Loading
Please wait while we load your information from QuoteMedia.